Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • COVID: One in every four persons have Covid-19 Antibodies in Kolkata

MythLysis: "Genetically modified crops: Harmful index reality check"

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

COVID: One in every four persons have Covid-19 Antibodies in Kolkata
  • BiotechToday
  • FEATURED
  • India
  • Latest

COVID: One in every four persons have Covid-19 Antibodies in Kolkata

bioxone September 12, 2020September 12, 2020

-Sayak Biswas, Amity University, Kolkata

During a time when the coronavirus is spreading like a wildfire across the whole world, a private laboratory in West Bengal has claimed that one in every four persons have Covid-19 Antibodies in Kolkata. This news has come as a relief to a State which has already seen over 1.87 lakh novel coronavirus cases including 3715 deaths till date.

The private laboratory claimed that it has done a sero survey among 3.5 lakh people across India recently. From West Bengal, a total of 22589 people was brought under this program and from Kolkata itself, 9050 people were included. Based on the study, the laboratory confirmed that at least 26 percent of the population of Kolkata and around 23 percent of the population of Bengal may have already developed Covid-19 antibodies while the National numbers stand at 27 percent. If this trend continues, experts feel herd immunity will be achieved faster than thought.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged corona virus Covid KOLKATA WEST BENGAL

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

bioxone September 12, 2020

-Anuska Sen, Team bioXone On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute. Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that […]

Related Post

  • BiotechToday
  • World

COVID-19 infection in a pregnant woman with liver cytolysis

bioxone November 20, 2020November 20, 2020

Husna, Amity University Kolkata The data on COVID-19 infections during pregnancy is limited. Although mortality or casualty due to the infection isn’t reported yet some adverse outcomes have been reported in the infants of women with covid-19 infections. The infant born to a COVID-19 infected mother has low birth weight, feeding intolerance, respiratory problems. Other […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Prognostic prediction score: A method to predict Pleuroparenchymal fibroelastosis

bioxone August 2, 2021August 2, 2021

Soumya Shraddhya Paul, Amity University, Noida Pleuroparenchymal fibroelastosis (PPFE) is an uncommon form of interstitial lung disease (ILD) that is characterised by elastofibrosis in the upper lobes. Patients with PPFE have several distinct clinical characteristics not seen in other ILDs. These are gradual weight loss and restrictive ventilatory dysfunction with increasing residual volume (RV). PPEE […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Cathepsin L inhibitor- A potential preventive of Covid-19?

bioxone April 11, 2021April 11, 2021

Ayooshi Mitra, Amity University, Kolkata UC San Diego researchers have long studied neglected tropical diseases, which are chronic and disabling parasitic infections that primarily affect underprivileged communities in developing countries. They are referred to as “neglected” because pharmaceutical companies have little financial incentive to develop therapies for them. Chagas disease, the leading cause of heart […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy